Universal Vision Biotechnology Co., Ltd. announced the change of the principal financial and accounting officer of the Company. Name, title, and resume of the previous position holder: Principle financial and accounting officer: Sophia Lien (Substitute); Name, title, and resume of the new position holder: Principle financial and accounting officer: Cindy Sun, vice president of financial department of Grand Pacific Investment & Development Co., Ltd.; senior financial manager of Chailease Finance; and assurance services manager of PricewaterhouseCoopers Taiwan; Reason for the change: Position adjustment; Effective date is October 20, 2022.
Universal Vision Biotechnology Co., Ltd.
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
249.5 TWD | +1.22% | -0.20% | -9.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.93% | 641M | |
+10.79% | 98.99B | |
-7.73% | 17.45B | |
-30.56% | 1.97B | |
+13.90% | 1.93B | |
+20.81% | 1.15B | |
+75.07% | 657M | |
-43.76% | 627M | |
-46.63% | 612M | |
+29.49% | 539M |
- Stock Market
- Equities
- 3218 Stock
- News Universal Vision Biotechnology Co., Ltd.
- Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes